References
1. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35: 2733-79.
2. Maron B.J., Rowin E.J., Udelson J.E., Maron M.S. Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy. JACC Heart Fail. 2018; 6 (5): 353-63.
3. Nishimura R.A, Seggewiss H., Schaff H.V. Hypertrophic obstructive cardiomyopathy. Surgical myectomy and septal ablation. Circ Res. 2017; 121: 771-83.
4. Panaich S.S., Badheka A.O., Chothani A. Results of ventricular septal myectomy and hypertrophic cardiomyopathy. Am J Cardiol. 2014; 114 (9): 1390-5.
5. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995; 346 (8969): 211-4.
6. Valeti U.S., Nishimura R.A., Holmes D.R., et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007; 49: 350-7.
7. Miklishanskaya C.V., Mazur N.A., Shestakova N.V. Mechanisms for the formation myocardial fibrosis in norm and in certain cardiovascular diseases. Meditsinskiy sovet [Medical Council]. 2017; 12: 75-81. (in Russian)
8. Lakkis N., Kleiman N., Killip D., Spencer W.H. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol. 1997; 20: 17-8.
9. Faber L., Seggewiss H., Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute and 3 months follow up results with respect to myocardial contrast echocardiography. Circulation. 1998; 98: 2415-21.
10. Naydenov R.A., Kretov E.I., Baystrukov V.I., Krest’yaninov O.V., Ibragimov R.U., Prokhorikhin A.A., et al. Evaluating the safety and effectiveness of Morrow myomectomy and alcohol-based myocardial reduction in patients with obstructive hypertrophic cardiomyopathy: a pilot randomized controlled trial. Patologiya krovoobrash-cheniya i kardiokhirurgiya [Pathology of Blood Circulation and Cardiac Surgery]. 2016; (3): 42-53. (in Russian)
11. Kim L.K., Swaminathan R.V., Looser P., Minu-tello R.M., Wong S.C., Bergman G., et al. Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide in-patient database, 2003-2011. JAMA Cardiol. 2016; 1: 324-32.
12. Raskin V.V., Frolova Yu.V., Malikova M.S., Dzemesh-kevich A.S., Dombrovskaya A.V., Shapieva A.N., et al. Tactics of surgical treatment of patients with a generalized form of obstructive hypertrophic cardiomyopathy. Klin-icheskaya i eksperimental’naya khirurgiya. Zhurnal imeni akademika B.V. Petrovskogo [Clinical and Experimental Surgery. Petrovsky Journal]. 2014; (1): 100-3. (in Russian)
13. Sorajja P., Ommen S.R., Holmes D.R. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012; 126 (20): 2374-80.
14. Polyakov R.S., Saakyan Yu.M., Puretskiy M.V., Pirkova A.A., Van E.Yu., Mardanyan G.V., et al. Interventional methods of treatment of hypertrophic cardiomyopathy. Klinicheskaya i eksperimental’naya khirurgiya. Zhurnal imeni akademika B.V. Petrovskogo [Clinical and Experimental Surgery. Petrovsky Journal]. 2014; (1): 969. (in Russian)
15. Poon S., Field M., Gupta D., Cameron D. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy? Interact Cardiovasc Thorac Surg. 2017; 24: 951-61.
16. Maron B.J., Nishimura R.A. Revisiting arrhythmic risk after alcohol septal ablation is the pendulum finally swinging. back to myectomy? JACC Heart Fail. 2014; 2 (6): 637-40.
17. Singh K., Qutub M., Carson K., Hibbert B., Glover C. A metaanalysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2016; 88 (1): 107-15.
18. Osman M., Kheiri B., Osman K., Barbarawi М., Alhamoud H., Alqahtani F., et al. Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: systematic review and meta-analysis. Clin Cardiol. 2019; 42: 190-7.
19. Nguyen A., Schaff H.V., Nishimura R.A., Dea-rani J.A., Geske J.B., Lahr B.D., et al. Determinants of reverse remodeling of the left atrium after transaortic myectomy. Ann Thorac Surg. 2018; 106 (2): 447-53.